Guo, YugangTang, LiXie, Yu-Qing2021-04-062021-04-062021-04-062021https://infoscience.epfl.ch/handle/20.500.14299/176993The present disclosure relates to new agents useful for anti-cancer therapy such as anti-cancer adoptive T-cell transfer (ACT) immunotherapy or immune check-point blockade therapy and related compositions, uses and methods thereof.patentUS2022370564JP2022548364EP4031564CN114728041BR112022005159MX2022003417KR20220065839AU2020351062CA3150050WO2021053134EP379558368069476